Shares of Aditxt Inc (ADTX) are trading 8% higher at a price of $3.645 at the time of this writing. While it's a cheerful day for the Health Care sector in general, the stock is flying past it's peers. The market is undergoing a significant macro move (2.13%) which could be a factor in the stock's movement.
- Aditxt, Inc. regained compliance with Nasdaq listing requirements;
- The company provided corporate highlights post-reverse stock split and closing of $20 million public offering.
Aditxt Inc has been trading between a 52-week high of $136 and a 52-week low of $2.58. The stock has a market cap of $208 Million.
Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies.
Is the Aditxt Inc. (NASDAQ:ADTX) stock an investment opportunity?
US Post News 09-30-22
Aditxt Inc. (NASDAQ: ADTX) Rise 10.46%, Now What? Don’t Panic
Stocks Register 09-30-22
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday''s Mid-Day Session
Nasdaq Tumbles Over 300 Points; Sunlight Financial Shares Plunge